OBJECTIVE: To standardize a method and determine normal values for absolute renal uptake of 99mTc-DMSA in children with normal creatinine clearance. MATERIALS AND METHODS: Twenty-two children (between 7 months and 10 years of age; mean 4.5 years) without clinical evidence of renal disease were studied using 99mTc-DMSA scintigraphy. Eighteen had normal renal ultrasonography, micturating urethrocystography, creatinine clearance and visual interpretation of the scintigraphy with 99mTc-DMSA. Four children were excluded, one with incomplete creatinine clearance and three due to reduction in the creatinine clearance. Absolute renal uptake of 99mTc-DMSA (DMSA-Abs) was expressed as the fraction of the administered dose retained by each kidney six hours after administration of the radiopharmaceutical. RESULTS: DMSA-Abs was 21.8 ± 3.2% for the right kidney and 23.1 ±3.3% for the left kidney. There was no correlation between renal uptake and the age groups studied, although there was a tendency to an increase in the creatinine clearance with age. CONCLUSION: Normal values of DMSA-Abs can be used as an additional parameter for the initial diagnostic evaluation and during follow-up of renal diseases, mainly when bilateral impairment of renal function is suspected or in a patient with a single functioning kidney (in which renal differential function is of limited value).

Keywords: Renal function, Quantification, 99mTc-DMSA, Children, Scintigraphy

OBJECTIVE: The present study was aimed at evaluating the viability of replacing ¹⁸F with ^99mTc in dose calibrator linearity testing. MATERIALS AND METHODS: The test was performed with sources of ^99mTc (62 GBq) and ¹⁸F (12 GBq) whose activities were measured up to values lower than 1 MBq. Ratios and deviations between experimental and theoretical ^99mTc and ¹⁸F sources activities were calculated and subsequently compared. RESULTS: Mean deviations between experimental and theoretical ^99mTc and ¹⁸F sources activities were 0.56 (± 1.79)% and 0.92 (± 1.19)%, respectively. The mean ratio between activities indicated by the device for the ^99mTc source as measured with the equipment pre-calibrated to measure ^99mTc and ¹⁸F was 3.42 (± 0.06), and for the ¹⁸F source this ratio was 3.39 (± 0.05), values considered constant over the measurement time. CONCLUSION: The results of the linearity test using ^99mTc were compatible with those obtained with the ¹⁸F source, indicating the viability of utilizing both radioisotopes in dose calibrator linearity testing. Such information in association with the high potential of radiation exposure and costs involved in ¹⁸F acquisition suggest ^99mTc as the element of choice to perform dose calibrator linearity tests in centers that use ¹⁸F, without any detriment to the procedure as well as to the quality of the nuclear medicine service.

Keywords: Nuclear medicine; Dose calibrator; Linearity test; Nuclear instrumentation.